Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from PW Medtech Group Ltd. ( (HK:1358) ) is now available.
PW Medtech Group Ltd. announced the first quarterly financial results for its subsidiary, Sichuan Ruijian Medical, showing a significant revenue increase of 43.89% compared to the previous year. This growth is attributed to the subsidiary’s expansion in domestic and overseas markets, increased brand awareness, and heightened market competitiveness, indicating a positive impact on the company’s market positioning and stakeholder interests.
More about PW Medtech Group Ltd.
PW Medtech Group Ltd., incorporated in the Cayman Islands, primarily focuses on investment holding and is engaged in the R&D, manufacturing, and sales of advanced medical devices, including infusion sets, intravenous cannula products, insulin needles, blood purification devices, and regenerative medical biomaterials in China.
Average Trading Volume: 874,932
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$1.61B
Learn more about 1358 stock on TipRanks’ Stock Analysis page.